About AAARNA
AAARNA is a Healthcare company based in Bengaluru (India) founded in 2017 by Pooja M Tiwari. MRNA-based therapeutics are developed for infectious and non-infectious human diseases. The company has 1 employees. Its chief executive, as recorded, is Pooja M Tiwari. Its Indian entity Aaarna Therapeutics Private Limited reported revenue of ₹44.4 Lakh. Its focus areas include Biopharma Outsourcing, CDMO, Biologics and Cell and Gene Therapy.
Company details
AAARNA was established in 2017 in Bengaluru, India, within the biotechnology sector. Focus is placed on creating mRNA-based therapeutics to address both infectious and non-infectious conditions. Proprietary mRNA synthesis technology is employed alongside various delivery systems. Operations support the health industry by enabling production of cost-effective therapeutics. Leadership includes co-founder and CEO Pooja M Tiwari. The companys domain is aaarna.com.
- Headquarters Bengaluru, India
- Employees 1
- Founders Pooja M Tiwari
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website aaarna.com
- Social LinkedIn X
- Legal Name Aaarna Therapeutics Private Limited
- Date of Incorporation 30 Sep, 2021
- Jurisdiction Nagpur, Maharashtra, India
- Annual Revenue₹44.4 Lakh
FY 2025 · -32% YoY
- Net Profit₹52,000
FY 2025 · 1% margin
- EBITDA₹72,000
FY 2025 · 2% margin
- Investors
- Employee Count1
Associated legal entities of AAARNA
AAARNA operates through Aaarna Therapeutics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aaarna Therapeutics Private Limited CIN U24230MH2021PTC368585 | Active | 30 Sep 2021 | Nagpur, Maharashtra | ₹0.4 Cr | 3 | View details |
Funding Insights of AAARNA
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of AAARNA with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2023 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in AAARNA
AAARNA has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include C-CAMP.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Bioscience research, innovation, and entrepreneurship facilitation in life sciences are conducted in India. | 2010 | ccamp.res.in | Bengaluru, India |
Investor details for AAARNA
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Aaarna Therapeutics Private Limited (AAARNA)
Aaarna Therapeutics Private Limited is the primary company behind AAARNA. The board of Aaarna Therapeutics Private Limited currently have 3 directors; the longest-serving is Subhash Veerbhadrappa Bawage, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Subhash Veerbhadrappa Bawage DIN 09341875 | Director | 30 Sep 2021 | 5 yrs 1 mo | Aaarna Therapeutics Private Limited |
| Shyam Munnilal Tiwari DIN 09341874 | Director | 30 Sep 2021 | 5 yrs 1 mo | Aaarna Therapeutics Private Limited |
| Pooja Munnilal Tiwari DIN 09840326 | Director | 26 Dec 2022 | 3 yrs 10 mo | Aaarna Therapeutics Private Limited |
People of AAARNA
1 people are tracked at AAARNA (1 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
| Co-Founder & CEO | Leadership |
Complete people profiles for AAARNA
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of AAARNA
Figures of Aaarna Therapeutics Private Limited, the primary company behind AAARNA, for FY 2025. Revenue was ₹44.4 Lakh (-32% year on year). Net profit was ₹52,000 (1% margin). EBITDA was ₹72,000 (2% margin).
- ₹44.4 LakhRevenue · FY 2025 · -32% YoY
- ₹52,000Net profit · 1% margin
- ₹72,000EBITDA · 2% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Aaarna Therapeutics Private Limited are on its company page.
Detailed financial statements for AAARNA
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of AAARNA
2 dated milestones of AAARNA across 6 years, from founding to its latest funding, stage changes and deals.
- Founded AAARNA is founded.
- Funding First funding round.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as AAARNA (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aaarna
Complete news archive for AAARNA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AAARNA
AAARNA was founded in 2017 and raised its 1st funding round 6 years after it was founded.
AAARNA is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Pooja M Tiwari is the CEO of AAARNA, as recorded in our data. They have also founded this company.
AAARNA has 1 employees.
The primary company behind AAARNA, Aaarna Therapeutics Private Limited, reported revenue of ₹44.4 Lakh for FY 2025, down 32% year on year.
AAARNA was established in 2017 in Bengaluru, India, within the biotechnology sector. Focus is placed on creating mRNA-based therapeutics to address both infectious and non-infectious conditions. Proprietary mRNA synthesis technology is employed alongside various delivery systems. Operations support the health industry by enabling production of cost-effective therapeutics. Leadership includes co-founder and CEO Pooja M Tiwari. The companys domain is aaarna.com.
AAARNA has 1 investor. Key investors include C-CAMP.
AAARNA operates through Aaarna Therapeutics Private Limited.
The legal entities of AAARNA currently have 3 directors, including Subhash Veerbhadrappa Bawage, Shyam Munnilal Tiwari, Pooja Munnilal Tiwari.